The Spectrum of Amniotic Fluid Embolism: Is Intralipid the solution ?
By Joseph Eldor
()
About this ebook
In 1998 it was first showed that intravenous Intralipid could prevent or improve resuscitation from cardiovascular collapse by severe bupivacaine overdose in rats. Since then published examples now include toxicities related to verapamil, diltiazem, amlodipine, quetiapine and sertraline, haldoperidol, lamotrigine, olanzapine, propranolol, atenolol, nevibolol, doxepin, dosulepin, imipramine, amitriptyline, glyosphate herbicide, flecainide, venlafaxine, moxidectin, and others. Amniotic fluid embolism (AFE) is a rare but potentially catastrophic obstetric emergency. Despite earlier recognition and aggressive treatment, morbidity and mortality rates remain high. An estimated 5% - 15% of all maternal deaths in Western countries are due to AFE. The pathophysiology of AFE is not completely understood. AFE most commonly occurs during labor, delivery, or the immediate postpartum period. However, it has been reported to occur up to 48 h postpartum. Pulmonary hypertension and right heart strain/failure may be the result of physical amniotic fluid debris in the pulmonary vasculature or, perhaps more likely, result from circulating pulmonary vasoconstrictive mediators. Therapy with Intralipid in male rats resulted in 100% survival and prevented Pulmonary arterial hypertension-induced right ventricular failure by preserving right ventricular pressure and right ventricular ejection fraction and preventing right ventricular hypertrophy and lung remodeling. In preexisting severe Pulmonary arterial hypertension, Intralipid attenuated most lung and right ventricular abnormalities. The beneficial effects of Intralipid in Pulmonary arterial hypertension seem to result from the interplay of various factors, among which preservation and/or stimulation of angiogenesis, suppression and/or reversal of inflammation, fibrosis and hypertrophy, in both lung and right ventricular, appear to be major contributors. In conclusion, Intralipid not only prevents the development of Pulmonary arterial hypertension and right ventricular failure but also rescues preexisting severe Pulmonary arterial hypertension. Intralipid treatment is a new treatment for AFE (amniotic fluid embolism).
Read more from Joseph Eldor
Quantum Consciousness Rating: 0 out of 5 stars0 ratingsCombined Spinal-Epidural Anesthesia Rating: 0 out of 5 stars0 ratingsIntralipid Is a Magic Bullet Rating: 0 out of 5 stars0 ratingsIntralipid and other Lipid Emulsions Rating: 0 out of 5 stars0 ratingsMatch Cognitive Brain Test Rating: 0 out of 5 stars0 ratingsIntralipid Rating: 0 out of 5 stars0 ratingsIntralipid infusion for Myelin Sheath Repair in Multiple Sclerosis and Trigeminal Neuralgia? Rating: 0 out of 5 stars0 ratingsIntralipid-Iodine for Imaging Rating: 0 out of 5 stars0 ratingsIntralipid Fatty Acids: The Code of Life ? Rating: 0 out of 5 stars0 ratingsIntralipid is a Magic Bullet in Cancer treatment? Rating: 0 out of 5 stars0 ratingsSerendipity Based Medicine (SBM) : To Infinity and Beyond Rating: 0 out of 5 stars0 ratingsBread Fat Rating: 0 out of 5 stars0 ratings
Related to The Spectrum of Amniotic Fluid Embolism
Related ebooks
Intralipid Rating: 0 out of 5 stars0 ratingsIntralipid Fatty Acids: The Code of Life ? Rating: 0 out of 5 stars0 ratingsThe HDL Handbook: Biological Functions and Clinical Implications Rating: 0 out of 5 stars0 ratingsPreclinical Physiology Review 2023: For USMLE Step 1 and COMLEX-USA Level 1 Rating: 0 out of 5 stars0 ratingsIntralipid-Iodine for Imaging Rating: 0 out of 5 stars0 ratingsPlasma Lipids: Optimal Levels for Health Rating: 0 out of 5 stars0 ratingsMetabolic Disorders and Critically Ill Patients: From Pathophysiology to Treatment Rating: 0 out of 5 stars0 ratingsChesley's Hypertensive Disorders in Pregnancy Rating: 0 out of 5 stars0 ratingsLiposomes in Nanomedicine Rating: 0 out of 5 stars0 ratingsDisorders of Albumin Metabolism in Liver Diseases Rating: 0 out of 5 stars0 ratingsLab Values Pocket Guide For Nurses Rating: 4 out of 5 stars4/5Hypocalcemia, (Low Blood Calcium) A Simple Guide To The Condition, Diagnosis, Treatment And Related Conditions Rating: 0 out of 5 stars0 ratingsMRCP(UK) and MRCP(I) Part II 200 Cases Rating: 0 out of 5 stars0 ratingsAlert Medical Series: USMLE Alert I, II, III Rating: 0 out of 5 stars0 ratingsEndocrinology: Modern Practical Nursing Series Rating: 0 out of 5 stars0 ratingsFast Facts: Hyperlipidemia: Bringing clarity to lipid management Rating: 0 out of 5 stars0 ratingsAlert Medical Series: Emergency Medicine Alert I Rating: 0 out of 5 stars0 ratingsThe use of cordyceps-containing products Rating: 0 out of 5 stars0 ratingsA Simple Guide to Hypovolemia, Diagnosis, Treatment and Related Conditions Rating: 0 out of 5 stars0 ratingsLipoprotein(a), The Heart's Quiet Killer: A Diet & Lifestyle Guide Rating: 5 out of 5 stars5/5Hypoglycemia in Diabetes: Pathophysiology, Prevalence, and Prevention Rating: 0 out of 5 stars0 ratingsBrain Lipids in Synaptic Function and Neurological Disease: Clues to Innovative Therapeutic Strategies for Brain Disorders Rating: 0 out of 5 stars0 ratingsHigh Density Lipoproteins, Dyslipidemia, and Coronary Heart Disease Rating: 0 out of 5 stars0 ratingsAlert Medical Series: Emergency Medicine Alert I, II, III Rating: 0 out of 5 stars0 ratingsArterial Blood Gas Interpretation in Clinical Practice Rating: 0 out of 5 stars0 ratingsDoctors Who Treated Cancer in The World Rating: 0 out of 5 stars0 ratingsAlert Medical Series: Internal Medicine Alert I, II, III Rating: 0 out of 5 stars0 ratingsEquine Fluid Therapy Rating: 0 out of 5 stars0 ratingsAntiphospholipid Syndrome Handbook Rating: 0 out of 5 stars0 ratingsThe Phlebotomy Technician Study Guide Rating: 4 out of 5 stars4/5
Medical For You
Women With Attention Deficit Disorder: Embrace Your Differences and Transform Your Life Rating: 5 out of 5 stars5/5The Vagina Bible: The Vulva and the Vagina: Separating the Myth from the Medicine Rating: 5 out of 5 stars5/5What Happened to You?: Conversations on Trauma, Resilience, and Healing Rating: 4 out of 5 stars4/5Brain on Fire: My Month of Madness Rating: 4 out of 5 stars4/5Mediterranean Diet Meal Prep Cookbook: Easy And Healthy Recipes You Can Meal Prep For The Week Rating: 5 out of 5 stars5/5The Emperor of All Maladies: A Biography of Cancer Rating: 5 out of 5 stars5/5Adult ADHD: How to Succeed as a Hunter in a Farmer's World Rating: 4 out of 5 stars4/5The People's Hospital: Hope and Peril in American Medicine Rating: 4 out of 5 stars4/5Herbal Healing for Women Rating: 4 out of 5 stars4/5The Diabetes Code: Prevent and Reverse Type 2 Diabetes Naturally Rating: 4 out of 5 stars4/5Gut: The Inside Story of Our Body's Most Underrated Organ (Revised Edition) Rating: 4 out of 5 stars4/5The Lost Book of Simple Herbal Remedies: Discover over 100 herbal Medicine for all kinds of Ailment Inspired By Barbara O'Neill Rating: 0 out of 5 stars0 ratingsThe Song of the Cell: An Exploration of Medicine and the New Human Rating: 4 out of 5 stars4/5Working Stiff: Two Years, 262 Bodies, and the Making of a Medical Examiner Rating: 4 out of 5 stars4/5ATOMIC HABITS:: How to Disagree With Your Brain so You Can Break Bad Habits and End Negative Thinking Rating: 5 out of 5 stars5/5Living Daily With Adult ADD or ADHD: 365 Tips o the Day Rating: 5 out of 5 stars5/5Tight Hip Twisted Core: The Key To Unresolved Pain Rating: 4 out of 5 stars4/5"Cause Unknown": The Epidemic of Sudden Deaths in 2021 & 2022 Rating: 5 out of 5 stars5/5The Art of Dying Well: A Practical Guide to a Good End of Life Rating: 4 out of 5 stars4/5A Letter to Liberals: Censorship and COVID: An Attack on Science and American Ideals Rating: 3 out of 5 stars3/5Hidden Lives: True Stories from People Who Live with Mental Illness Rating: 4 out of 5 stars4/5Holistic Herbal: A Safe and Practical Guide to Making and Using Herbal Remedies Rating: 4 out of 5 stars4/5Rewire Your Brain: Think Your Way to a Better Life Rating: 4 out of 5 stars4/5The Hormone Reset Diet: Heal Your Metabolism to Lose Up to 15 Pounds in 21 Days Rating: 4 out of 5 stars4/5
Reviews for The Spectrum of Amniotic Fluid Embolism
0 ratings0 reviews
Book preview
The Spectrum of Amniotic Fluid Embolism - Joseph Eldor
1. Is INTRALIPID the solution?
In 1998 it was first showed that intravenous Intralipid could prevent or improve resuscitation from cardiovascular collapse by severe bupivacaine overdose in rats. Since then published examples now include toxicities related to verapamil, diltiazem, amlodipine, quetiapine and sertraline, haldoperidol, lamotrigine, olanzapine, propranolol, atenolol, nevibolol, doxepin, dosulepin, imipramine, amitriptyline, glyosphate herbicide, flecainide, venlafaxine, moxidectin, and others. Amniotic fluid embolism (AFE) is a rare but potentially catastrophic obstetric emergency. Despite earlier recognition and aggressive treatment, morbidity and mortality rates remain high. An estimated 5% - 15% of all maternal deaths in Western countries are due to AFE. The pathophysiology of AFE is not completely understood. AFE most commonly occurs during labor, delivery, or the immediate postpartum period. However, it has been reported to occur up to 48 h postpartum. Pulmonary hypertension and right heart strain/failure may be the result of physical amniotic fluid debris in the pulmonary vasculature or, perhaps more likely, result from circulating pulmonary vasoconstrictive mediators. Therapy with Intralipid in male rats resulted in 100% survival and prevented Pulmonary arterial hypertension-induced right ventricular failure by preserving right ventricular pressure and right ventricular ejection fraction and preventing right ventricular hypertrophy and lung remodeling. In preexisting severe Pulmonary arterial hypertension, Intralipid attenuated most lung and right ventricular abnormalities. The beneficial effects of Intralipid in Pulmonary arterial hypertension seem to result from the interplay of various factors, among which preservation and/or stimulation of angiogenesis, suppression and/or reversal of inflammation, fibrosis and hypertrophy, in both lung and right ventricular, appear to be major contributors. In conclusion, Intralipid not only prevents the development of Pulmonary arterial hypertension and right ventricular failure but also rescues preexisting severe Pulmonary arterial hypertension. Intralipid treatment is a new treatment for AFE (amniotic fluid embolism) which was never suggested before (1).
Its first clinical use was done in Texas A&M University System Health Science Center College of Medicine, Baylor Scott & White Health, Temple, Texas on a 28-year-old otherwise healthy, nonsmoking, 76-kg primigravid woman presented at 41 weeks of gestation for vaginal misoprostol induction of labor (2).
Despite several administrations of ACLS medications including vasopressin, sodium bicarbonate, calcium chloride, atropine, and a total of 6 mg epinephrine, the patient’s heart rhythm fluctuated between profound bradycardia and asystole for a prolonged period of 40 minutes
.
As a last resort, IV lipid 20% emulsion (1.5mL/kg) was administered as a bolus. Within 30 to 90 seconds, the patient had return of spontaneous circulation, normal sinus rhythm, and dramatic improvement in left and right ventricular function, shown clearly by TEE. After several minutes, the patient’s condition slowly deteriorated once again to asystole, at which time CPR was once again started and a second lipid emulsion bolus (1.5mL/kg) was administered and followed with an infusion at 0.25mL/kg/min. Within 30 to 60 seconds, the patient again had a return of spontaneous circulation with normal sinus rhythm. In addition, she also exhibited spontaneous movements of her extremities.
Although Eldor and Kotlovker (13) were the first to suggest a possible benefit of lipid emulsion therapy in the treatment of AFE, this is the first published instance in which a patient received intravenous lipid emulsion temporally related to the recovery from cardiovascular collapse associated with amniotic fluid embolism. The main limitation is the fact that AFE is a diagnosis of exclusion; however, other differential diagnoses are less likely. There is TEE evidence that shows overall improvement of cardiac function temporally related to administration of lipid emulsion. The patient had return of spontaneous circulation occurring shortly after the administration of lipid emulsion on 2 different occasions after exhausting all other ACLS options, suggesting that lipid emulsion may have been responsible for the successful resuscitation. In addition, after the initial improvement, a relapse occurred, which was treated with a second bolus of lipid emulsion after which the same improvement in clinical and cardiac function occurred. Full neurologic recovery was noted after significantly prolonged cardiovascular collapse with chest compressions (40 minutes) and exhaustion of other standard ACLS medications. The excellent neurologic recovery emphasizes the importance of high quality and sustained CPR. Furthermore, a possible physiologic mechanism for the cardiopulmonary recovery is presented and is based on scientific models from previous research on the effects of lipid emulsion and its components. This report suggests a possible benefit of lipid emulsion therapy in the treatment of cardiovascular collapse caused by AFE, and further research will be required to elucidate the role of lipid emulsion therapy in the setting of AFE.
References
1. Joseph Eldor, Vladimir Kotlovker. Intralipid for Amniotic Fluid Embolism (AFEJ. Open Journal of Anesthesiology Vol.2 No.4(2012), https://file.scirp.org/Html/7-1920052_22244.htm
2. Windrik Lynch, MD, Russell K. McAllister, MD, Jack F. Lay Jr, MBA, MD, and William C. Culp Jr, MD. Lipid Emulsion Rescue of Amniotic Fluid Embolism Induced Cardiac Arrest: A Case Report. A&A Case Reports. 2017;8:64-66.
http://www.csen.com/AFE.pdf
2. The Intralipid Sink Effect
Papadopoulou A et al. (1) hypothesized that by substituting a dye surrogate in place of local anesthetic, they could visually demonstrate dye sequestration by lipid emulsion that would be dependent on both dye lipophilicity and the amount of lipid emulsion used.
They selected 2 lipophilic dyes, acid blue 25 and Victoria blue, with log P values comparable to lidocaine and bupivacaine, respectively. Each dye solution was mixed with combinations of lipid emulsion and water to emulate lipid rescue
treatment at dye concentrations equivalent to fatal, cardiotoxic, and neurotoxic local anesthetic plasma concentrations. The lipid emulsion volumes added to each dye solution emulated equivalent intravenous doses of 100, 500, and 900 mL of 20% Intralipid in a